Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2005 2
2008 1
2009 2
2010 3
2011 6
2012 4
2013 13
2014 8
2015 10
2016 13
2017 20
2018 8
2019 9
2020 28
2021 30
2022 21
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma.
Aso A, Aiba H, Traversari M, Righi A, Gambarotti M, Atherley O'Meally A, Solou K, Cammelli S, Bordini B, Cosentino M, Zuccheri F, Dozza B, Frega G, Ibrahim T, Manfrini M, Donati DM, Errani C. Aso A, et al. Among authors: ibrahim t. Skeletal Radiol. 2024 May 7. doi: 10.1007/s00256-024-04702-7. Online ahead of print. Skeletal Radiol. 2024. PMID: 38713225
Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48].
Hernando J, Roca-Herrera M, García-Álvarez A, Raymond E, Ruszniewski P, Kulke MH, Grande E, Carbonero RG, Castellano D, Salazar R, Ibrahim T, Teule A, Alonso V, Fazio N, Valle JW, Tafuto S, Carmona A, Navarro V, Capdevila J. Hernando J, et al. Among authors: ibrahim t. Eur J Cancer. 2024 May;203:114061. doi: 10.1016/j.ejca.2024.114061. Epub 2024 Apr 12. Eur J Cancer. 2024. PMID: 38609739 No abstract available.
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group.
Palassini E, Baldi GG, Sulfaro S, Barisella M, Bianchi G, Campanacci D, Fiore M, Gambarotti M, Gennaro M, Morosi C, Navarria F, Palmerini E, Sangalli C, Sbaraglia M, Trama A, Asaftei S, Badalamenti G, Bertulli R, Bertuzzi AF, Biagini R, Bonadonna A, Brunello A, Callegaro D, Cananzi F, Cianchetti M, Collini P, Comandini D, Curcio A, D'Ambrosio L, De Pas T, Dei Tos AP, Ferraresi V, Ferrari A, Franchi A, Frezza AM, Fumagalli E, Ghilli M, Greto D, Grignani G, Guida M, Ibrahim T, Krengli M, Luksch R, Marrari A, Mastore M, Merlini A, Milano GM, Navarria P, Pantaleo MA, Parafioriti A, Pellegrini I, Pennacchioli E, Rastrelli M, Setola E, Tafuto S, Turano S, Valeri S, Vincenzi B, Vitolo V, Ivanescu A, Paloschi F, Casali PG, Gronchi A, Stacchiotti S. Palassini E, et al. Among authors: ibrahim t. Cancer Treat Rev. 2024 May;126:102722. doi: 10.1016/j.ctrv.2024.102722. Epub 2024 Mar 30. Cancer Treat Rev. 2024. PMID: 38604052 Free article. Review.
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects.
Fusco V, Di Maio M, Valsecchi AA, Santini D, Tucci M, De Giorgi U, Bossi P, Ibrahim T, Cavanna L, Lanzetta G, Rossi M, Rossetti G, Airoldi M, Comandone A, Cinieri S. Fusco V, et al. Among authors: ibrahim t. Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8. Support Care Cancer. 2024. PMID: 38427111 Free PMC article.
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.
Guerrieri AN, Bellotti C, Penzo M, Columbaro M, Pannella M, De Vita A, Gambarotti M, Mercatali L, Laranga R, Dozza B, Vanni S, Corsini S, Frisoni T, Miserocchi G, Ibrahim T, Lucarelli E. Guerrieri AN, et al. Among authors: ibrahim t. BMC Cancer. 2023 Dec 6;23(1):1194. doi: 10.1186/s12885-023-11658-9. BMC Cancer. 2023. PMID: 38057796 Free PMC article.
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Lucarelli E, De Vita A, Bellotti C, Frisoni T, Vanni S, Guerrieri AN, Pannella M, Mercatali L, Gambarotti M, Duchi S, Miserocchi G, Maioli M, Liverani C, Ibrahim T. Lucarelli E, et al. Among authors: ibrahim t. Cancers (Basel). 2023 Oct 25;15(21):5132. doi: 10.3390/cancers15215132. Cancers (Basel). 2023. PMID: 37958307 Free PMC article. Review.
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report.
Palmerini E, Frega G, Gambarotti M, Frisoni T, Cesari M, Bazzocchi A, Miceli M, Donati DM, Fanti S, Nanni C, Benini S, Longhi A, Paioli A, Marrari A, Hakim R, Righi A, Ibrahim T. Palmerini E, et al. Among authors: ibrahim t. Front Oncol. 2023 Oct 9;13:1252359. doi: 10.3389/fonc.2023.1252359. eCollection 2023. Front Oncol. 2023. PMID: 37876963 Free PMC article.
Myoepithelial carcinoma of soft tissues and bone.
Aiba H, Errani C, Ciani G, Gambarotti M, Righi A, Maioli M, Spinnato P, Frega G, Ibrahim T, Longhi A. Aiba H, et al. Among authors: ibrahim t. Eur J Cancer. 2023 Nov;194:113353. doi: 10.1016/j.ejca.2023.113353. Epub 2023 Sep 26. Eur J Cancer. 2023. PMID: 37852042
188 results